AcelRx Pharmaceuticals Operating Margin 2009-2020 | ACRX

Current and historical operating margin for AcelRx Pharmaceuticals (ACRX) over the last 10 years. The current operating profit margin for AcelRx Pharmaceuticals as of June 30, 2020 is -1131.00%.
AcelRx Pharmaceuticals Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2020-06-30 $0.00B $-0.05B -1300.00%
2020-03-31 $0.00B $-0.06B -2900.00%
2019-12-31 $0.00B $-0.05B -2700.00%
2019-09-30 $0.00B $-0.05B -1666.67%
2019-06-30 $0.00B $-0.05B -2250.00%
2019-03-31 $0.00B $-0.04B -1950.00%
2018-12-31 $0.00B $-0.04B -1750.00%
2018-09-30 $0.00B $-0.03B -1600.00%
2018-06-30 $0.00B $-0.03B -1066.67%
2018-03-31 $0.01B $-0.04B -700.00%
2017-12-31 $0.01B $-0.04B -487.50%
2017-09-30 $0.01B $-0.04B -292.31%
2017-06-30 $0.02B $-0.04B -246.67%
2017-03-31 $0.02B $-0.04B -205.88%
2016-12-31 $0.02B $-0.03B -188.24%
2016-09-30 $0.01B $-0.03B -253.85%
2016-06-30 $0.03B $-0.02B -72.00%
2016-03-31 $0.02B $-0.02B -81.82%
2015-12-31 $0.02B $-0.02B -105.26%
2015-09-30 $0.02B $-0.02B -141.18%
2015-06-30 $0.01B $-0.04B -514.29%
2015-03-31 $0.01B $-0.04B -800.00%
2014-12-31 $0.01B $-0.04B -760.00%
2014-09-30 $0.03B $-0.01B -18.18%
2014-06-30 $0.03B $-0.01B -31.03%
2014-03-31 $0.03B $-0.01B -17.24%
2013-12-31 $0.03B $-0.01B -23.33%
2013-09-30 $0.00B $-0.04B -875.00%
2013-06-30 $0.00B $-0.04B -1166.67%
2013-03-31 $0.00B $-0.03B -1133.33%
2012-12-31 $0.00B $-0.03B -1500.00%
2012-09-30 $0.00B $-0.03B -2800.00%
2012-06-30 $0.00B $-0.03B -2500.00%
2012-03-31 $0.00B $-0.02B -2300.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.129B $0.002B
AcelRx Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of pain. The Company product candidates comprises: ARX-01 or the Sufentanil NanoTab PCA System; ARX-02 or the Sufentanil NanoTab BTP Management System; and ARX-03 or the Sufentanil/Triazolam NanoTab which are in their development stage. Its product ARX-01 is focused on acute post-operative pain, ARX-02 is focused on the treatment of cancer breakthrough pain and ARX-03 is focused on providing mild sedation, anxiety reduction, and pain relief to patients undergoing painful procedures in a physician's office. AcelRx Pharmaceuticals, Inc. is headquartered in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.202B 43.91
Takeda Pharmaceutical (TAK) Japan $57.191B 9.97
Astellas Pharma (ALPMY) Japan $28.020B 14.20
Eisai (ESALY) Japan $26.847B 22.69
UCB SA (UCBJF) Belgium $22.660B 0.00
Merck (MKGAF) Germany $18.934B 24.83
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $14.015B 45.56
Grifols, S.A (GRFS) Spain $11.558B 14.13
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $9.111B 35.27
IPSEN SA ADR (IPSEY) France $8.650B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.931B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.750B 12.82
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Orion OYJ (ORINY) Finland $7.077B 24.56
Ionis Pharmaceuticals (IONS) United States $6.773B 42.90
United Therapeutics (UTHR) United States $4.487B 10.37
Arrowhead Pharmaceuticals (ARWR) United States $4.442B 0.00
Evotec AG (EVTCY) Germany $3.927B 136.32
FibroGen (FGEN) United States $3.761B 0.00
ChemoCentryx (CCXI) United States $3.688B 0.00
Hypermarcas (HYPMY) Brazil $3.313B 12.19
PTC Therapeutics (PTCT) United States $3.200B 0.00
Sage Therapeutics (SAGE) United States $3.101B 0.00
Nektar Therapeutics (NKTR) United States $3.022B 0.00
Pacira BioSciences (PCRX) United States $2.538B 66.73
Xencor (XNCR) United States $2.242B 0.00
Revolution Medicines (RVMD) United States $2.240B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.086B 10.10
Corcept Therapeutics (CORT) United States $2.028B 18.67
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.838B 0.00
Cronos Group (CRON) Canada $1.767B 0.00
USANA Health Sciences (USNA) United States $1.522B 14.34
Ironwood Pharmaceuticals (IRWD) United States $1.507B 10.47
Heron Therapeutics (HRTX) United States $1.348B 0.00
Trillium Therapeutics (TRIL) Canada $1.333B 0.00
Indivior (INVVY) United States $1.185B 14.69
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.154B 11.00
Karyopharm Therapeutics (KPTI) United States $1.072B 0.00
Esperion Therapeutics (ESPR) United States $1.042B 0.00
Translate Bio (TBIO) United States $1.011B 0.00
Zogenix (ZGNX) United States $0.995B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.964B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.900B 560.38
Vectura Group (VEGPF) United Kingdom $0.828B 0.00
Endo (ENDP) Ireland $0.752B 1.11
VAXART, INC (VXRT) United States $0.745B 0.00
Collegium Pharmaceutical (COLL) United States $0.686B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.677B 0.00
ImmunoGen (IMGN) United States $0.621B 0.00
Tilray (TLRY) Canada $0.614B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.609B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.561B 0.00
Siga Technologies (SIGA) United States $0.548B 58.42
Aerie Pharmaceuticals (AERI) United States $0.532B 0.00
Molecular Templates (MTEM) United States $0.524B 0.00
Radius Health (RDUS) United States $0.518B 0.00
Flexion Therapeutics (FLXN) United States $0.513B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.496B 0.00
Ocular Therapeutix (OCUL) United States $0.492B 0.00
Ardelyx (ARDX) United States $0.472B 0.00
TherapeuticsMD (TXMD) United States $0.438B 0.00
Altimmune (ALT) United States $0.428B 0.00
Organogenesis Holdings (ORGO) United States $0.409B 0.00
Harpoon Therapeutics (HARP) United States $0.404B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.387B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.386B 19.27
Redhill Biopharma (RDHL) Israel $0.361B 0.00
MEI Pharma (MEIP) United States $0.354B 0.00
DURECT (DRRX) United States $0.351B 0.00
Akebia Therapeutics (AKBA) United States $0.343B 0.00
PROFOUND MEDICL (PROF) Canada $0.337B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.332B 8.23
IMV INC (IMV) Canada $0.309B 0.00
Innate Pharma SA (IPHYF) France $0.298B 0.00
Concert Pharmaceuticals (CNCE) United States $0.286B 0.00
Jounce Therapeutics (JNCE) United States $0.280B 13.26
Menlo Therapeutics (VYNE) United States $0.277B 0.00
Xeris Pharmaceuticals (XERS) United States $0.270B 0.00
Rafael Holdings (RFL) United States $0.259B 0.00
Calithera Biosciences (CALA) United States $0.243B 0.00
Lannett Co Inc (LCI) United States $0.239B 5.56
KalVista Pharmaceuticals (KALV) United States $0.226B 0.00
Nature's Sunshine Products (NATR) United States $0.223B 21.96
Oasmia Pharmaceutical AB (OASMY) Sweden $0.206B 0.00
Nivalis Therapeutics (ALPN) United States $0.205B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.192B 0.00
CASI Pharmaceuticals (CASI) United States $0.192B 0.00
Heat Biologics (HTBX) United States $0.183B 0.00
Otonomy (OTIC) United States $0.180B 0.00
OptiNose (OPTN) United States $0.176B 0.00
Taiwan Liposome (TLC) Taiwan $0.169B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.161B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.156B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.153B 0.00
Aquestive Therapeutics (AQST) United States $0.148B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.138B 0.00
Champions Oncology (CSBR) United States $0.118B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.112B 0.00
Aclaris Therapeutics (ACRS) United States $0.109B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.109B 0.00
MediWound (MDWD) Israel $0.104B 0.00
Lipocine (LPCN) United States $0.091B 0.00
Biomerica (BMRA) United States $0.084B 0.00
Hemispherx BioPharma (AIM) United States $0.084B 0.00
CTI BioPharma (CTIC) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.073B 0.00
ElectroCore (ECOR) United States $0.073B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.072B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.071B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.069B 0.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
Novan (NOVN) United States $0.067B 0.00
Addex Therapeutics (ADXN) Switzerland $0.066B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.059B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.057B 0.00
CV Sciences (CVSI) United States $0.055B 0.00
Recro Pharma (REPH) United States $0.050B 0.00
Onconova Therapeutics (ONTX) United States $0.050B 0.00
Natural Alternatives (NAII) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 29.09
SCYNEXIS (SCYX) United States $0.046B 0.00
India Globalization Capital (IGC) United States $0.045B 0.00
ProPhase Labs (PRPH) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
IsoRay (ISR) United States $0.040B 0.00
PolarityTE (PTE) United States $0.040B 0.00
GTx (ONCT) United States $0.035B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.96
Bellicum Pharmaceuticals (BLCM) United States $0.034B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.032B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.031B 0.00
AgeX Therapeutics (AGE) United States $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.029B 0.00
Neos Therapeutics (NEOS) United States $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
Vical (BBI) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.024B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Sundial Growers (SNDL) Canada $0.020B 0.00
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.016B 23.64
Iterum Therapeutics (ITRM) Ireland $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
JanOne (JAN) United States $0.009B 0.00
China SXT Pharmaceuticals (SXTC) China $0.009B 0.00
Shineco (TYHT) China $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00